Bay Area Top Selling Drugs of 2013

Home/Financial/Bay Area Top Selling Drugs of 2013

Bay Area Top Selling Drugs of 2013

GEN has a new “Top” list – the top selling drugs of 2013 – and several Bay Area firms/partnered efforts made the list:

#15. Breo Ellipta/ Relvar Ellipta (fluticasone furoate and vilanterol inhalation [FF/VI] powder)

2013 Sales: $13.492 million (£8 million)

Marketer(s): GlaxoSmithKline and Theravance2

#14. Imbruvica (ibrutinib)

2013 Sales: $13.6 million3

Marketer(s): Pharmacyclics and Janssen Biotech (Johnson & Johnson)

 

#4. Sovaldi (sofosbuvir)

2013 Sales: $139.435 million

Marketer(s): Gilead Sciences

#3. Kadcyla (ado-trastuzumab emtansine)

2013 Sales: $266.214 million (CHF 234 million)

Marketer(s): Genentech, a member of the Roche Group

 

Full list and information here.

May 12th, 2014|
X